Ali Asif 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Ali Asif（CIK 1921163）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 15,650 | $300,324 |
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 5,312 | $64,647 |
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 12,595 | $1.8M |
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 46,034 | $6.5M |
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 9,229 | $359,746 |
| 2026-10-02 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 28,438 | $666,018 |
| 2026-04-21 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 1,750 | $184,572 |
| 2026-03-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 19,500 | $374,205 |
| 2026-03-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 5,265 | $64,075 |
| 2026-03-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 24,765 | $2.6M |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 12,000 | $146,040 |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 16,000 | $307,040 |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 28,000 | $2.3M |
| 2026-01-27 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 18,203 | $1.5M |
| 2026-01-21 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 8,588 | $708,338 |
| 2026-01-06 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 买入 | 25,600 | $0 |
| 2025-04-23 | Protagonist Therapeutics, Inc (PTGX) | Chief Financial Officer | 卖出 | 1,756 | $80,776 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02